DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

Translate to Spanish or other 102 languages!

Dr. R. Alejandro Cruz, DHR Health Neurologist. Photo Courtesy DHR Health
- Advertisement -

Edinburg, Texas: DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

Under the expert guidance of neurologist Dr. R. Alejandro Cruz and the dedicated team at the DHR Health Neuroscience Institute, comprehensive protocols have been meticulously developed for administering Leqembi. These protocols encompass every aspect of patient care, from initial assessments to laboratory testing, radiology procedures, and establishing a state-of-the-art infusion center.

“I am very proud of the hard work of our team at DHR Health. Being the first facility to provide this groundbreaking therapy for Alzheimer’s disease marks a new era of hope for our community,” said Dr. R. Alejandro Cruz, DHR Health Neurologist.

- Advertisement -

As the largest physician-owned hospital in the United States and a leading healthcare provider in the Rio Grande Valley, DHR Health is immensely proud to be at the forefront of Alzheimer’s disease treatment in South Texas. “This achievement represents our ongoing commitment to bringing innovative and advanced treatment options to our community. We are proud to provide world-class care close to home,” said Marissa Castañeda, Senior Executive Vice President at DHR Health.

Dr. Cruz explains that Alzheimer’s disease is a progressive brain disorder characterized by changes in the brain that lead to the accumulation of certain proteins. These changes cause the brain to shrink and brain cells to die, resulting in dementia, which manifests as a gradual decline in memory, thinking, behavior, and social skills. The introduction of Leqembi offers hope for those affected by this debilitating condition, with the potential to improve quality of life and slow disease progression.

DHR Health continues delivering exceptional care, announcing a new chapter in Alzheimer’s treatment for the Rio Grande Valley. If you or a loved one are affected by Alzheimer’s, we encourage you to take the next step. To learn more about this groundbreaking treatment or to make an appointment, please contact the DHR Health Neuroscience Institute at (956) 362-8500.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

TMA Honors Georgetown Pediatrician for a Career of Distinguished Service 

The Texas Medical Association (TMA) has honored Georgetown pediatrician John W. Hellerstedt, MD, with the 2026 TMA Distinguished Service Award in recognition of his 45 years of exemplary service to patients, public health, and organized medicine.   

STC opens Wellness Center at Health Science Professions Campus

South Texas College recently inaugurated a new Wellness Center at its Health Science Professions Campus in McAllen, giving students, faculty and staff free access to a space designed to support both physical and mental well-being.

STHS McAllen Helps Hospitalized Patient Celebrate Sacred Wedding

On April 10, 2001, Craig Ellis and Maria Christina “Christy” GarciaEllis stood before a judge and their exchanged vows in a civil ceremony due to Christy’s previous marriage.

STC Student Emerges as a Model for Future Leaders in Occupational Therapy

Mega Doctor News By Selene Rodriguez Driven by a determination to help children...
- Advertisement -